Healthcare News and Research

Latest Healthcare News and Research

Terminally-ill patients often denied chance to die at home

Many terminally-ill patients cannot die at home because of a lack of services and training in palliative care, say researchers from the University of Warwick.

8 May 2007

Percutaneous radiofrequency ablation of liver tumors safe and effective

Percutaneous imaging guided radiofrequency ablation (RFA) of hepatocellular carcinoma is a safe and effective technique, with benefits such as reduced post-procedural pain and length of hospital stay, according to a study conducted by researchers from Changi General Hospital in Singapore.

8 May 2007

Scientists create cheaper 3-D ultrasound device

Almost every doctor's surgery has an ultrasound scanner. Medical ultrasonography allows us to see an unborn child in its mother's womb and helps to detect gall stones or identify tumor-like lumps.

8 May 2007

Migraines take a toll on employers as well!

Data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.

4 May 2007

Pittsburgh Groups to tell lawmakers to fix health care system

A coalition of national, state and Pittsburgh organizations will host a press conference urging visiting Pennsylvania lawmakers to endorse Governor Rendell's "Prescription for Pennsylvania" healthcare proposal.

4 May 2007

New prostate cancer treatment wins award for Sloan-Kettering

The unique application of operations research to the treatment of prostate cancer allowed Memorial Sloan-Kettering Cancer Center to better Fortune 500 companies last night and win an international competition for best project by an organization.

4 May 2007

AIDS Healthcare Foundation praises Thailand for drug stance

AIDS Healthcare Foundation (AHF) has lauded the Government of Thailand for its vow to continue with plans to issue compulsory licenses for the manufacturing and importing of generic versions of lifesaving drugs, including AIDS drugs, despite the fact that the office of United States Trade Representative (USTR), elevated Thailand to its 'Priority Watch' List.

4 May 2007

Use of antithrombotics means more intracerebral haemorrhagic stroke deaths in over 75s

A study suggests that the number of pensioners over 75 dying from intracerebral haemorrhagic stroke has increased in the last 25 years due to use of antithrombotic drugs.

2 May 2007

Liver stiffness indicates severe portal hypertension in patients with hepatitis C-related cirrhosis

Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis, according to a new study in the May issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).

2 May 2007

Eli Lilly to publish grant and contribution information

Eli Lilly and Company has announced that it will begin posting online all educational grant funding and other monetary contributions provided to U.S.-based organizations.

2 May 2007

New assessment model gauges lung cancer risk

Clinicians may be one step closer to having a critical tool in identifying which smokers are at higher risk for developing lung cancer, the deadliest of all cancers, thanks to an assessment model generated by researchers at The University of Texas M. D. Anderson Cancer Center.

2 May 2007

AARP says "enough is enough" in Illinois health care reform

With health care costs soaring and the number of uninsured people in Illinois climbing to nearly 1.5 million, AARP says enough is enough, things have to change.

2 May 2007

Millions wasted each year in Britain on asthma

An asthma charity in Britain says more than £40 million a year could be saved if asthma sufferers were given better advice on how to manage their condition.

2 May 2007

Newly founded National Institute for Quality Improvement and Education

The newly founded National Institute for Quality Improvement and Education (NIQIE) is a not-for-profit organization dedicated to the integration of quality improvement and continuing education for healthcare professionals.

1 May 2007

Community leaders engage lawmakers on the value Medicare Advantage

More than three dozen community leaders from across the country have come together to actively engage lawmakers on the value Medicare Advantage provides to vulnerable seniors in their communities.

1 May 2007

3M and Gen-Probe collaborate to combat healthcare-associated infections

3M and Gen-Probe have announced that the companies have formed an exclusive worldwide collaboration to develop and commercialize rapid, easy-to-use nucleic acid tests to detect certain dangerous healthcare-associated infections (HCAIs) such as methicillin-resistant Staphylococcus aureus (MRSA).

1 May 2007

Many NYC pharmacies fail to cater for people with poor English

Despite widespread capacity to provide prescription medication labels in languages other than English, few New York City pharmacies do so and as a result, limited-English patients face serious risk of medication error, according to a study by The New York Academy of Medicine presented at the annual meeting of the Society for General Internal Medicine (SGIM) in Toronto, Ontario.

30 Apr 2007

FDA approves INVEGA treatment for schizophrenia

The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.

30 Apr 2007

Ranbaxy receives approval to manufacture Pravastatin Sodium tablets in U.S.

Ranbaxy Pharmaceuticals has announced that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Pravastatin Sodium Tablets (Pravastatin), 10 mg, 20 mg, 40 mg and 80 mg, with 180-day market exclusivity in the U.S. healthcare system for the 80 mg strength.

27 Apr 2007

Ranbaxy receives approval to manufacture Zolpidem tablets for insomnia

Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.

27 Apr 2007